NEW YORK, Sept. 14, 2022 /PRNewswire/ -- The ligases enzyme market revenue will be $631.7 million by 2030, growing from $367.4 million in 2021 at a 6.2% CAGR. This is attributed to the growing usage of these chemicals in the detection of infectious diseases and genetic abnormalities, along with the booming cancer burden.
North America Generates Highest Revenue, Led by U.S.
- The highest revenue in the market, of $224.7 million, was generated in North America last year. The extensive R&D activities in disease diagnostics and treatment using these enzymes will allow the region to keep dominating the market over this decade.
- A hub for biotechnology, the region is witnessing an increasing usage of these agents in protein engineering, PCR, cloning, mutation detection, drug target, and NGS.
- The U.S. holds the larger share in the ligases enzyme market of North America, due to the high incidence of genetic defects and a rise in the number of people needing long-term care. Additionally, the government efforts aimed at the utilization of ligases enzymes in molecular diagnosis tools drives the country's market.
Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/ligases-enzyme-market-size/report-sample
T4 DNA ligases, the largest category, will witness a 6.8% CAGR, the highest within the product segment. T4 DNA is used for the effective and quick ligation of blunt double-stranded as well as cohesive-ended DNA fragments during molecular diagnoses; it is also used for T/A cloning.
Considered a highly flexible ligase, T4 DNA is the popular choice in the majority of traditional molecular cloning procedures. T4 DNA offers effective ligation in high temperatures and media with high salt concentrations. Additionally, this biological agent achieves ligation in merely 5 minutes at room temperature, with the use of a specialty optimized buffer.
As a source for these agents, Escherichia coli generates almost 35% of the ligases enzyme market revenue, as DNA ligases obtained from this bacterium were the first to be extracted and analyzed. Additionally, the presence of its own ligase allows E. coli to join the ends of recombinant DNA in a cell. As a result, DNA ligase from E. coli is used to join two fragments of recombinant DNA, before the complete DNA is embedded into a cell.
The largest category within the application segment, molecular cloning will have a size of $134.8 million in 2030. This method is used to create recombinant DNA and replicate them inside cells. As a result, molecular cloning is used to clone stem cells, to treat a variety of diseases, and to obtain a better understanding of genetic conditions.
Browse detailed report on Ligases Enzyme Market Size, Share and Demand Forecast to 2030
With revenue of $135.5 million, research laboratories and institutions lead the ligases enzyme market on the basis of end user. This is attributed to the role of these institutions in biotechnology research, which brings about innovations in the domain of genetic testing. Moreover, research labs are extensively working to discover the biological and chemical modulators of ligases enzyme targets with regulatory approval.
Ligases Enzyme Market Report Coverage
By Product
- Quick Ligase
- T4 DNA Ligase
- E. Coli DNA Ligase
- Tth DNA Ligase
- T4 RNA Ligase
- Pfu DNA Ligase
By Source
- Archaebacterium
- Escherichia coli
- Thermus thermophilus
- Pyrococcus furiosus
By Application
- Ligase Chain Reaction
- Ligase Detection Reaction
- Next-Generation Sequencing
- Repeat Expansion Detection
- Rolling Circle Amplification
- Proximity Ligation Assay
- Molecular Cloning
- Ligation Mediated PCR
- Mutation Detection
By End User
- Research Laboratories and Institutions
- Pharmaceutical and Biopharmaceutical Companies
- Diagnostic Laboratories
Regional Analysis
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Asia-Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Columbia
- Chile
- Middle East and Africa
- Saudi Arabia
- South Africas
Browse More Reports Published by P&S
Global DNA Extraction Kit Market Size, Share and Demand Forecast to 2030
Global Microarray Analysis Market Size, Share and Demand Forecast to 2030
Global Epigenetics Market Size, Share and Demand Forecast to 2030
About P&S Intelligence
P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.
Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: [email protected]
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter
SOURCE P&S Intelligence
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article